Nicholson Meyer Capital Management’s AbbVie ABBV Stock Holding History

Nicholson Meyer Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$264K	Hold	1,050	–	–	0.18%	41
2026 Q1	$228K	Hold	1,050	–	–	0.18%	40
2025 Q4	$240K	Hold	1,050	–	–	0.18%	40
2025 Q3	$243K	Buy	+1,050	New	+$214K	0.19%	40
2025 Q2	–	Sell	-1,050	Closed	-$220K	–	46
2025 Q1	$220K	Buy	+1,050	New	+$204K	0.2%	43

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Nicholson Meyer Capital Management's ABBV Position: Q2 2026 in Review

Nicholson Meyer Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,050 shares worth $264K. The position accounts for 0.18% of the portfolio, ranked #41.

Nicholson Meyer Capital Management first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nicholson Meyer Capital Management held 1,050 shares of AbbVie worth $264K as of Q2 2026.
Nicholson Meyer Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.18% of Nicholson Meyer Capital Management's portfolio in Q2 2026, its #41 holding.
Nicholson Meyer Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nicholson Meyer Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.